Pure Global

Investigating Novel Smoking Cessation Primary Care Interventions in Rural Environments - Trial NCT05764759

Access comprehensive clinical trial information for NCT05764759 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of South Carolina and is currently Recruiting. The study focuses on Smoking Cessation. Target enrollment is 288 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05764759
Recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT05764759
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Investigating Novel Smoking Cessation Primary Care Interventions in Rural Environments
Addressing Rural Cancer Disparities Via Proactive Smoking Cessation Treatment Within Primary Care: A Hybrid Type 1 Effectiveness-Implementation Trial of a Scalable Smoking Cessation Electronic Visit

Study Focus

Smoking Cessation

Smoking cessation e-visit

Interventional

behavioral

Sponsor & Location

Medical University of South Carolina

Charleston, United States of America

Timeline & Enrollment

N/A

Mar 07, 2023

Aug 15, 2027

288 participants

Primary Outcome

Smoking Cessation,Smoking Cessation,Smoking Cessation,Reduction in Cigarettes Per Day,Reduction in Cigarettes Per Day,Reduction in Cigarettes Per Day

Summary

The purpose of this research study is to evaluate an electronic visit (e-visit) for smoking
 cessation across rural primary care settings. Participants will be randomly assigned to
 receive either the smoking cessation e-visit or not. The e-visit will look similar to an
 online questionnaire asking about smoking history, motivation to quit, and preferences for
 medications for quitting smoking. Participants may receive a prescription for a smoking
 cessation medication as an outcome of the e-visit, if randomized to the e-visit group, but
 there is no requirement to take any medication. This study consists of questionnaires and
 breath samples provided at 4 separate time points throughout the study. Participation in this
 study will take about 24 weeks.

ICD-10 Classifications

Mental and behavioural disorders due to use of tobacco withdrawal state
Tobacco use
Exposure to tobacco smoke
Toxic effect: Tobacco and nicotine
Mental and behavioural disorders due to use of tobacco

Data Source

ClinicalTrials.gov

NCT05764759

Non-Device Trial